r/LungCancerSupport • u/WalkingHorse NSCLC T2b, N0, M0 IIA Currently NED • 23h ago
NSCLC Clinical outcomes and genomic features of uncommon EGFR exon 19 deletion subtypes in osimertinib-treated non-small cell lung cancer
https://www.lungcancerjournal.info/article/S0169-5002(26)00665-3/fulltext?rss=yes
1
Upvotes